CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MRK

Infusion of 5 mg/kg Infliximab

Phase 2
MERCK (MRK)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
MRKPhase 2

Infusion of 5 mg/kg Infliximab Phase 2 Est. Readout

Infusion of 5 mg/kg Infliximab
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Acute Pancreatitis

View Full Landscape
Drug Information

Target Indication

Acute Pancreatitis

Clinical Trial

NCT03684278

Last updated: 10/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.